Group One Trading’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.95M Buy
149,215
+26,543
+22% +$703K 0.01% 182
2025
Q1
$2.96M Sell
122,672
-144,081
-54% -$3.48M 0.01% 200
2024
Q4
$10.7M Buy
266,753
+2,645
+1% +$106K 0.02% 61
2024
Q3
$16.7M Buy
264,108
+62,814
+31% +$3.98M 0.05% 34
2024
Q2
$10.7M Buy
201,294
+127,049
+171% +$6.73M 0.04% 68
2024
Q1
$6.09M Buy
74,245
+51,320
+224% +$4.21M 0.02% 95
2023
Q4
$427K Sell
22,925
-504,536
-96% -$9.39M ﹤0.01% 563
2023
Q3
$5.84M Buy
527,461
+31,966
+6% +$354K 0.02% 108
2023
Q2
$8.03M Sell
495,495
-20,457
-4% -$332K 0.03% 58
2023
Q1
$8.59M Sell
515,952
-235,959
-31% -$3.93M 0.03% 53
2022
Q4
$7.07M Buy
751,911
+604,295
+409% +$5.68M 0.02% 99
2022
Q3
$402K Buy
147,616
+26,458
+22% +$72.1K ﹤0.01% 630
2022
Q2
$350K Buy
121,158
+1,214
+1% +$3.51K ﹤0.01% 712
2022
Q1
$360K Buy
119,944
+30,528
+34% +$91.6K ﹤0.01% 859
2021
Q4
$411K Buy
89,416
+16,651
+23% +$76.5K ﹤0.01% 964
2021
Q3
$457K Buy
72,765
+9,599
+15% +$60.3K ﹤0.01% 865
2021
Q2
$378K Sell
63,166
-6,107
-9% -$36.5K ﹤0.01% 904
2021
Q1
$438K Sell
69,273
-258,124
-79% -$1.63M ﹤0.01% 814
2020
Q4
$1.84M Buy
327,397
+188,463
+136% +$1.06M ﹤0.01% 343
2020
Q3
$809K Buy
138,934
+10,543
+8% +$61.4K ﹤0.01% 418
2020
Q2
$926K Sell
128,391
-1,323
-1% -$9.54K ﹤0.01% 315
2020
Q1
$607K Buy
129,714
+114,641
+761% +$536K ﹤0.01% 324
2019
Q4
$121K Sell
15,073
-106,361
-88% -$854K ﹤0.01% 759
2019
Q3
$835K Buy
121,434
+88,820
+272% +$611K 0.01% 270
2019
Q2
$271K Sell
32,614
-42,670
-57% -$355K ﹤0.01% 477
2019
Q1
$748K Sell
75,284
-119,988
-61% -$1.19M 0.01% 232
2018
Q4
$1.49M Sell
195,272
-236,241
-55% -$1.81M 0.01% 189
2018
Q3
$7.52M Buy
431,513
+256,658
+147% +$4.47M 0.06% 40
2018
Q2
$1.66M Buy
174,855
+145,896
+504% +$1.38M 0.01% 189
2018
Q1
$127K Buy
+28,959
New +$127K ﹤0.01% 697